These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14612107)

  • 1. Technical limitations of immunosuppressive drug therapy blood level monitoring.
    Masri MA; Rizk S; Kamel G; Barbari A; Stephan A
    Transplant Proc; 2003 Nov; 35(7):2755-6. PubMed ID: 14612107
    [No Abstract]   [Full Text] [Related]  

  • 2. Specimen dilution for C2 monitoring with the Abbott TDxFLx cyclosporine monoclonal whole blood assay.
    Juenke JM; Brown PI; Urry FM; McMillin GA
    Clin Chem; 2004 Aug; 50(8):1430-3. PubMed ID: 15277354
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine lymphocyte level and lymphocyte count: new guidelines for tailoring immunosuppressive therapy.
    Barbari A; Stephan A; Masri M; Mourad N; Kamel G; Kilani H; Karam A; Daya IA
    Transplant Proc; 2003 Nov; 35(7):2742-4. PubMed ID: 14612101
    [No Abstract]   [Full Text] [Related]  

  • 4. New approaches to cyclosporine monitoring raise further concerns about analytical techniques.
    Holt DW; Johnston A; Kahan BD; Morris RG; Oellerich M; Shaw LM
    Clin Chem; 2000 Jun; 46(6 Pt 1):872-4. PubMed ID: 10839783
    [No Abstract]   [Full Text] [Related]  

  • 5. Falsely elevated whole blood cyclosporine concentrations measured by an immunoassay with automated pretreatment.
    Bartoli A; Molinaro M; Visai L
    Ther Drug Monit; 2010 Dec; 32(6):791-2. PubMed ID: 21068651
    [No Abstract]   [Full Text] [Related]  

  • 6. [The clinical usefulness of cyclosporine therapeutic monitoring].
    Di Fede G; Iacò V; Pepe S; Salerno L
    Clin Ter; 1999; 150(5):339-42. PubMed ID: 10687263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclosporine].
    Yuhki Y; Tadano K; Takahashi Y
    Nihon Rinsho; 1999 Sep; 57 Suppl():428-31. PubMed ID: 10543145
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine A: peak or trough level monitoring in renal transplant recipients?
    Wacke R; Drewelow B; Kundt G; Hehl EM; Bast R; Seiter H
    Transplant Proc; 2001; 33(7-8):3122-3. PubMed ID: 11750342
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cyclosporine].
    Yuhki Y; Tadano K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():461-4. PubMed ID: 15658363
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine level: which single-point estimation of drug level is the best?
    Sharma R; Kumar J; Ahmed M; Gupta A; Gulati S; Sharma AP; Bhandari M
    Transplant Proc; 2001; 33(7-8):3124-5. PubMed ID: 11750343
    [No Abstract]   [Full Text] [Related]  

  • 11. [Program of external quality control in cyclosporine dosage: summary and analysis from French laboratories].
    Marquet P; Perrin A; Billaud E; Méninat F; Johnston A; Holt DW; Vassault A
    Ann Biol Clin (Paris); 1999 May; 57(3):360-3. PubMed ID: 10377491
    [No Abstract]   [Full Text] [Related]  

  • 12. 12th quality assessment of cyclosporin blood monitoring by 56 Japanese laboratories.
    Takagi H; Uchida K; Takahara S; Takahashi K
    Transplant Proc; 1998 Aug; 30(5):1706-8. PubMed ID: 9723250
    [No Abstract]   [Full Text] [Related]  

  • 13. Apparent elevation of cyclosporine whole blood concentrations in a renal allograft recipient.
    de Jonge H; Geerts I; Declercq P; de Loor H; Claes K; Desmet K; Kuypers DR
    Ther Drug Monit; 2010 Oct; 32(5):529-31. PubMed ID: 20625351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine therapeutic drug monitoring.
    Jensen SA; Dalhoff KP
    Transplant Proc; 2001 Sep; 33(6):3003-5. PubMed ID: 11543826
    [No Abstract]   [Full Text] [Related]  

  • 15. Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome.
    Fujinaga S; Kaneko K; Takada M; Ohtomo Y; Akashi S; Yamashiro Y
    Pediatr Nephrol; 2005 Sep; 20(9):1359-60. PubMed ID: 15918005
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimization of cyclosporine therapy in the Neoral era: abbreviated AUC, single blood sampling?
    Gaspari F; Caruso R; Cattaneo D; Perico N; Remuzzi G
    Transplant Proc; 2001; 33(7-8):3117-9. PubMed ID: 11750340
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic monitoring by blood concentrations with the focus on cyclosporin A].
    Jensen SA; Dalhoff KP
    Ugeskr Laeger; 2001 Apr; 163(14):2009-12. PubMed ID: 11307363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of C-0 to C-2 monitoring of cyclosporine in stable kidney transplant patients.
    Jirasiritham S; Mavichak V; Danviriyasup K; Jirasiritham S
    Transplant Proc; 2003 Feb; 35(1):236-7. PubMed ID: 12591379
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality assurance programs for immunosuppressive drugs: cyclosporine and beyond.
    Holt DW; Marwaha G; Jones K; Johnston A
    Ther Drug Monit; 1993 Dec; 15(6):472-7. PubMed ID: 8122279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipients.
    Braun F; Armstrong VW; Lorf T; Canelo R; Arndt C; Oellerich M; Ringe B
    Transplant Proc; 2001; 33(7-8):3108-9. PubMed ID: 11750336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.